The Eleven Fund

The Eleven Fund is a growth equity firm established in 2017, located in Denver, Colorado. The firm specializes in late-stage pre-IPO investments, focusing on sectors such as technology, life sciences, and consumer markets. By targeting companies poised for significant growth, The Eleven Fund aims to provide capital to businesses that are approaching their public offerings, helping them to scale and succeed in competitive environments.

Hart Wasko

Founder and Managing Partner

2 past transactions

Alleaves

Series A in 2022
Alleaves is a cannabis technology company that cultivates, manufactures, and sells cannabis. The company delivers the products with AI-based automated dispatch and ETAs, real-time fleet tracking, and analytics. The company's contact modes are by mail and at its physical address.

Pear Therapeutics

Post in 2021
Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company's platform combines novel digital interventions with drugs to enhance efficacy well beyond anything that is commercially available or in clinical development, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective services for payors.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.